Employees Retirement System Of Texas Ligand Pharmaceuticals Inc Transaction History

Employees Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $547,360 - $1.19 Million	-5,500 Reduced 43.04%	7,279 $1.11 Million
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $424,436 - $591,307	-4,921 Reduced 27.8%	12,779 $1.27 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $859,040 - $1.03 Million	-8,000 Reduced 31.13%	17,700 $2.02 Million
Q1 2019 May 14, 2019	BUY	$105.93 - $142.47 $317,790 - $427,410	3,000 Added 13.22%	25,700 $3.23 Million
Q4 2018 Feb 12, 2019	BUY	$128.36 - $272.13 $256,720 - $544,260	2,000 Added 9.66%	22,700 $3.08 Million
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $1.35 Million - $1.76 Million	-6,400 Reduced 23.62%	20,700 $5.68 Million
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $904,620 - $1.25 Million	-6,000 Reduced 18.13%	27,100 $5.61 Million
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $1.54 Million - $1.76 Million	12,000 Added 56.87%	33,100 $4.53 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $1.09 Million - $1.24 Million	9,000 Added 74.38%	21,100 $2.87 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,100	12,100 $1.47 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Employees Retirement System Of Texas with notifications on news.